See the DrugPatentWatch profile for Delstrigo
Delstrigo is a prescription medication used for the treatment of HIV-1 infection. It is a combination tablet containing three active antiretroviral drugs: doravirine, lamivudine, and tenofovir disoproxil fumarate [1]. This single-tablet regimen is taken orally once daily [1].
What is Delstrigo approved for?
Delstrigo is indicated for use in adult patients as a complete regimen for the treatment of HIV-1 infection [1].
What are the key components of Delstrigo?
Delstrigo is a fixed-dose combination tablet containing:
* Doravirine: A non-nucleoside reverse transcriptase inhibitor (NNRTI) [1].
* Lamivudine: A nucleoside reverse transcriptase inhibitor (NRTI) [1].
* Tenofovir disoproxil fumarate (TDF): Another NRTI [1].
What are the recommended dosages and administration instructions for Delstrigo?
The recommended dosage of Delstrigo is one tablet taken orally once daily, with or without food [1].
What are the potential side effects of Delstrigo?
The most common side effects reported in clinical trials include dizziness, nausea, diarrhea, and fatigue [1]. Serious side effects can occur, and it is important to discuss these with a healthcare provider [1].
Are there any specific warnings or precautions for Delstrigo?
Patients taking Delstrigo should be aware of potential risks, including liver problems, lactic acidosis, and fat redistribution [1]. It is crucial to inform a healthcare provider about any pre-existing medical conditions, especially kidney or liver disease, and any other medications being taken to avoid drug interactions [1].
How does Delstrigo work to treat HIV-1?
Delstrigo combines three antiretroviral agents that work by inhibiting the HIV-1 reverse transcriptase enzyme. Doravirine blocks the enzyme directly, while lamivudine and tenofovir disoproxil fumarate act as nucleoside analogs that are incorporated into the viral DNA, leading to chain termination. This multi-drug approach targets different stages of the HIV replication cycle, helping to suppress viral load [1].
What are the drug interactions associated with Delstrigo?
Delstrigo can interact with various medications, including certain antacids, anticonvulsants, and other antiretrovirals [1]. A complete list of potential drug interactions is available in the prescribing information, and patients should always consult their healthcare provider about all medications, including over-the-counter drugs and supplements, they are taking [1].
Where can I find the official Delstrigo package insert?
The official Delstrigo package insert, also known as the prescribing information, contains comprehensive details about the drug's use, safety, and efficacy. It is typically available from the manufacturer or through official drug information databases [1].